Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy

Recruiting now · Not applicable

Conditions studied: Gynecologic Malignancy

In brief

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.

Key facts

Study ID

NCT06997887

Run by

National Taiwan University Hospital

People needed

60

Starts

2025-05-09

Expected to finish

2030-05-09

Last updated by the study team

2025-06-27

Who can join

Age: 20 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients aged between 20 and 70 years.
• Completion of pelvic radiotherapy for gynecologic cancer, which may include external beam radiotherapy (EBRT), brachytherapy (BT), or a combination of both.
• Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1.

You may not qualify if…

• Individuals under the age of 18.
• Presence of distant metastases or a history of malignancy currently under treatment within the past five years (excluding non-melanoma skin cancer).
• Presence of severe comorbidities, such as uncontrolled diabetes, cardiovascular disease, or autoimmune disorders that may interfere with treatment or study participation.
• Diagnosed psychiatric disorders or significant social factors that may prevent adherence to study requirements or completion of follow-up evaluations.
• Inability to self-administer vaginal gel or vaginal rehabilitation exercises.

Where it is running

• National Taiwan University Cancer Center — Taipei, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.